NCT01897025

Brief Summary

Stroke is the most common cause of adult disability. Current treatments for functional loss of the upper extremity post-stroke remain limited in efficacy, particularly for those with moderate to severe impairment. Previous studies have demonstrated the efficacy of transcranial direct current stimulation (tDCS) for motor recovery post-stroke, a technique of neuromodulation. Motor imagery is effective to enhance motor recovery, with activation of neural pathways similar to that of motor execution. This treatment is accessible to more severely impaired stroke survivors. Our previous studies have demonstrated feasibility and efficacy of motor imagery-based brain computer interface (MI-BCI) for post-stroke motor impairment, in which motor imagery is detected by surface EEG and translated to execution of the target movement with the aid of an arm robot (MIT-Manus). In this study, we investigate the feasibility of combining robot-assisted MI-BCI training, with tDCS to facilitate post-stroke motor recovery in moderate to severe impairment of upper extremity function. We hypothesise that both tDCS-BCI and sham-BCI will improve motor function in the stroke-affected arm; but that tDCS-BCI will be more effective than sham-BCI. Our secondary aim is to gain insight into the neurophysiological mechanism by comparing the cortical excitability changes following sham-BCI vs tDCS-BCI, using transcranial magnetic stimulation (TMS). We will conduct a randomized, double-blinded study with MI-BCI combined with tDCS (tDCS-BCI) vs MI-BCI combined with sham-tDCS (sham tDCS-BCI). Subjects will undergo 10 sessions of tDCS each lasting 20 minutes, followed by 40 minutes of robot-assisted MI-BCI training at each session. Primary outcome will be functional ability measured by upper extremity component of the Fugl-Meyer Assessment. Secondary outcome measures will be the Box \& Block Test, Modified Ashworth Score (measuring spasticity), grip strength and measures of brain activity including transcranial magnetic stimulation (TMS) measures of magnetic resonance imaging (MRI) measures including functional MRI and diffusion tensor imaging (DTI). This study will be important to develop a new and effective treatment (tDCS-BCI) for post-stroke motor impairment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for phase_2 stroke

Timeline
Completed

Started Jan 2011

Typical duration for phase_2 stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

July 8, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 11, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

March 10, 2016

Completed
Last Updated

March 10, 2016

Status Verified

February 1, 2016

Enrollment Period

3 years

First QC Date

July 8, 2013

Results QC Date

July 28, 2015

Last Update Submit

February 11, 2016

Conditions

Keywords

StrokeNoninvasive brain stimulationBrain-computer interfaceMotor imageryRehabilitation

Outcome Measures

Primary Outcomes (1)

  • Upper Extremity Component of Fugl-Meyer Assessment

    The total FMA score (range, 0-66) on the stroke-impaired upper extremity was used to measure the motor improvements in this study. Higher score indicates better upper limb motor function. FMA were measured at 3 time points: at baseline (wk 0), at completion of intervention (wk 2), and at a 2-week follow-up (wk 4).

    week 0, week 2, week 4

Secondary Outcomes (4)

  • Resting Motor Threshold of Stroke Affected M1 Motor Cortex

    pre- and post-training, 4 weeks post-training

  • Grip Strength

    pre- and post-training, and again at 4 weeks post-training

  • Box and Block Test

    pre and post training, and 4 weeks post training

  • MRI Parameters

    -2, 0 and 4 weeks

Study Arms (2)

real-tDCS with MI-BCI

ACTIVE COMPARATOR

10 sessions of the following: 20 minutes of tDCS prior to each session of motor training with the MI-BCI system. Direct current at an intensity of 1mA with anode placed over the M1 motor cortex of the affected hemisphere and the cathode placed over the unaffected M1. After initial calibration, MI-BCI training will involve motor imagery of reaching tasks using the clock game interface of the MIT-Manus robotic system to perform multi-directional reaching movements. Upon detection of the intention to move towards the target on BCI, the robotic arm will complete the reaching movement towards the target. Each training session will last for 40 minutes excluding set-up time.

Device: real-tDCS with MI-BCI

sham-tDCS with MI-BCI

SHAM COMPARATOR

10 sessions of sham tDCS with BCI motor training, each session of which will be conducted as follows: The same electrode placement and stimulation parameters will be employed for sham tDCS as for real tDCS. However, the current will be applied for 30 seconds only, to give subjects the sensation of the stimulation. This method of sham stimulation has also been validated (Gandiga et al., 2006). Current intensity will be increased and decreased gradually to decrease perception. MI-BCI training will be the same as the real-tDCS group and will similarly last for 40 minutes.

Device: real-tDCS with MI-BCI

Interventions

As in Arm Description

real-tDCS with MI-BCIsham-tDCS with MI-BCI

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • first ever haemorrhagic or ischaemic subcortical stroke more than 9 months prior to study enrollment
  • upper extremity impairment of 11-45 on the Fugl-Meyer assessment scale

You may not qualify if:

  • epilepsy
  • neglect
  • cognitive impairment
  • other neurological or psychiatric diseases
  • severe arm pain
  • spasticity score \>2 on the Modified Ashworth Scale in the shoulder or elbow
  • contraindications to TMS or tDCS (cranial implants, ventricular shunts, pacemakers, intrathecal pumps)
  • grip strength \<10kg as measured by a dynamometer
  • participation in other interventions or trials targeting stroke motor recovery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National University Hospital

Singapore, Singapore, 119074, Singapore

Location

Related Publications (3)

  • Elsner B, Kugler J, Pohl M, Mehrholz J. Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke. Cochrane Database Syst Rev. 2020 Nov 11;11(11):CD009645. doi: 10.1002/14651858.CD009645.pub4.

  • Chew E, Teo WP, Tang N, Ang KK, Ng YS, Zhou JH, Teh I, Phua KS, Zhao L, Guan C. Using Transcranial Direct Current Stimulation to Augment the Effect of Motor Imagery-Assisted Brain-Computer Interface Training in Chronic Stroke Patients-Cortical Reorganization Considerations. Front Neurol. 2020 Aug 27;11:948. doi: 10.3389/fneur.2020.00948. eCollection 2020.

  • Ang KK, Guan C, Phua KS, Wang C, Zhao L, Teo WP, Chen C, Ng YS, Chew E. Facilitating effects of transcranial direct current stimulation on motor imagery brain-computer interface with robotic feedback for stroke rehabilitation. Arch Phys Med Rehabil. 2015 Mar;96(3 Suppl):S79-87. doi: 10.1016/j.apmr.2014.08.008.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Dr Effie Chew
Organization
National University Hospital

Study Officials

  • Effie Chew, MBBS

    National University Hospital, Singapore

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2013

First Posted

July 11, 2013

Study Start

January 1, 2011

Primary Completion

January 1, 2014

Study Completion

January 1, 2014

Last Updated

March 10, 2016

Results First Posted

March 10, 2016

Record last verified: 2016-02

Locations